Results 121 to 130 of about 118,695 (310)

Estonian results from the monitoring of pesticide residues in food

open access: yes, 2018
This dataset contains the analytical results of pesticide residues measured in the food products analysed by the national competent authorities. Pesticide residues resulting from the use of plant protection products on crops that are used for food or ...
Veterinary and Food Board (6753644)   +1 more
core   +1 more source

A sustainable business ecosystem: a case study demonstrating biochar's potential

open access: yesBiofuels, Bioproducts and Biorefining, EarlyView.
Abstract The need for renewable, climate‐friendly resources has become urgent as legislators worldwide have sought to find ways to cut emissions while ensuring resource security for consumers. The use of biochar could help to achieve these goals. This study examines the current state of commercial biochar production and the maturity of the related ...
Kivijakola Juuso   +4 more
wiley   +1 more source

EU-welfare legislation on pigs

open access: yes, 2010
An inventory was performed of 1) the present situation regarding the implementation of Directive 2008/120/EC and 2) national government funded research related to the Directive.
Vermeij, I.   +3 more
core  

Understanding the impact of legislation on 'reduction of disease risk' claims on food and drinks: The REDICLAIM project [PDF]

open access: yes, 2016
The Nutrition and Health Claims Regulation (EC No. 1924/2006) has established a common framework for the regulation of nutrition and health claims used on foods across the European Union.
Cleary, A   +12 more
core  

Bulgarian results from the monitoring of pesticide residues in food

open access: yes, 2018
<p>This dataset contains the analytical results of pesticide residues measured in the food products analysed by the national competent authorities.
Bulgarian Food Safety Agency   +1 more
core   +1 more source

Status of oncology drugs with a conditional approval: A cross‐sectional comparison of the Food and Drug Administration and Health Canada

open access: yesBritish Journal of Clinical Pharmacology, EarlyView.
Aims This study looks at the status of the same drugs conditionally approved by the Food and Drug Administration and Health Canada for the same oncology indication. Methods Lists of oncology drugs with a conditional approval from the Food and Drug Administration and Health Canada were generated and drug pairs with the same indication were matched ...
Joel Lexchin
wiley   +1 more source

Food Waste Legislation Scholarship: A Mapping Study

open access: yes, 2019
The purpose of this study is to examine research activity on food waste legislation published in law journals to identify top sources and experts cited by recent scholarship.
Hackstadt, Angela
core   +1 more source

Paediatric development of radiopharmaceutical imaging agents and radioligand therapeutics

open access: yesBritish Journal of Clinical Pharmacology, EarlyView.
Abstract This review focuses on the development of radiopharmaceutical imaging agents and radioligand therapeutics for paediatric use. Nuclear medicine plays an important role in the diagnosis and treatment of various childhood conditions, including cancers, infections and brain disorders.
Justin L. Hay   +5 more
wiley   +1 more source

Norwegian results from the monitoring of pesticide residues in food

open access: yes, 2018
<p>This dataset contains the analytical results of pesticide residues measured in the food products analysed by the national competent authorities.
Norwegian Food safety Authority   +1 more
core   +1 more source

Beyond the label: Rethinking off‐label drug use in paediatrics. Towards a scientifically grounded and safer future for paediatric pharmacotherapy

open access: yesBritish Journal of Clinical Pharmacology, EarlyView.
Abstract Despite regulatory progress being made in the past two decades, off‐label drug use in paediatrics remains pervasive, with prevalence estimated between 3% and 97% of prescriptions across different clinical settings. Off‐label use—defined as prescribing outside the conditions described in the Summary of Product Characteristics (SmPC)—is often ...
Tjitske M. van der Zanden   +3 more
wiley   +1 more source

Home - About - Disclaimer - Privacy